Dr. Essam Hamza reports

TREATMENT.COM AI ANNOUNCES AI PHARMACY ASSISTANT

Treatment.com AI Inc. will roll out a new solution, AI Pharmacy Assistant, designed to support pharmacists. Pharmacists are playing an increasing role in the provision of clinical decision support services, given the increasing number of people without a GP and/or the time taken to book appointments.

As one example, the Ontario government recently announced pharmacies provided over one million assessments for common ailments since last year. This is representative of similar trends being seen across Canada, the United Kingdom and emerging legislation in the United States, all of which will lead to extending the role for pharmacists within the health care continuum of care. Globally, pharmacists will play a significant role in alleviating the shortages of health care professionals, timeliness of patient support and mitigating the financial pressures prevalent in today's health care systems.

For many people, especially in underserved communities, the pharmacist is often the only health care professional people see. Therefore, providing these pharmacists with the tools and confidence to administer a wider range of services has a positive impact for them and the well-being of their communities.

Working with pharmacists, Treatment is excited to be announcing its new AI Pharmacy Assistant solution for pharmacists, expected to launch later in 2024. The solution is underpinned by Treatment's AI powered proprietary global library of medicine (GLM), the most comprehensive and integrated on-line medical library. The GLM has been created with hundreds of credentialled clinicians globally to ensure the highest qualified clinical information and support to all healthcare professionals.

AI Pharmacy Assistant will be either accessible on a patient's mobile device or through a kiosk tablet at the pharmacy. It will support pharmacists in multiple ways:

• Reducing the time to take patient histories and symptoms using Treatment's GLM;
• Automatically document all interactions with patients providing an audit trail;
• Extending confidence and support in expanded diagnostic support provided to patients;
• Minimize the risk of errors and increase clinical efficiency;
• Providing comprehensive diagnostic and symptom information backed by the most reliable and up-to-date medical research.

The global clinical decision support systems (CDSS) market is projected to grow significantly, reaching approximately $4.05-billion by 2029 from $2.46-billion in 2024, driven by technological advancements and the integration of AI and machine learning in health care decision-making processes. Whilst there is a clear desire to expand the pharmacist's scope of practice, there is also a huge shortage of pharmacists globally. Therefore, pharmacists are being stretched at both ends: more work, less staff. Supportive and accurate support tools which can be trusted, such as Treatment's AI Pharmacy Assistant, will be a pivotal part of the solution.

Dr. Essam Hamza, chief executive officer of Treatment.com AI, comments: "We are excited to announce another new product line and revenue stream for our GLM platform. We have been working closely with industry professionals and government agencies to ensure we create a valuable tool that will have the most immediate impact for all the stakeholders. For payers, we help improve efficiency and hopefully avoid patient complications and unneeded costly hospital visits. For the pharmacists, we help relieve administrative headaches and give them comfort to see more patients. Finally, and most importantly, for the patient, we provide more and better access to care for themselves and their family members."

About Treatment.com AI Inc.

Treatment.com AI is a company utilizing AI to positively disrupt the health care sector and impact current inefficiencies and challenges.

We seek Safe Harbor.